Position in NTRA
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$28,230
+$10,231 QoQ
Shares Held
104
+15.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#716
of 844 holders
Holding Since
Dec 2022
12 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026CVA Family Office, LLC holds $2,058,804 across 22 Diagnostics & Research names. NTRA ranks #13 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
1,475 | $739,506 | |
| 2 | DHR |
Danaher Corp /De/
|
2,555 | $486,676 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
768 | $148,392 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
275 | $144,771 | |
| 5 | A |
Agilent Technologies, Inc.
|
877 | $116,491 | |
| 6 | WAT |
Waters Corp /De/
|
186 | $69,757 | |
| 7 | DGX |
Quest Diagnostics Inc
|
256 | $54,259 | |
| 8 | ILMN |
Illumina, Inc.
|
290 | $50,990 |
All Filings in NTRA
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,230 | 104 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $17,999 | 90 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $9,163 | 40 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $8,048 | 50 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $13,853 | 82 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $6,787 | 48 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $791 | 5 | Shares | Sole | 2025-01-07 | |
| 2024-09-30 | $634 | 5 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $541 | 5 | Shares | Sole | 2024-07-10 | |
| 2023-06-30 | $243 | 5 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $277 | 5 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $200 | 5 | Shares | Sole | 2023-02-22 | |
| No filing history on record for this holder in this stock. | ||||||